PURPOSE: To determine the value of MR contrast enhancement in predicting the course of acute inflammatory facial nerve palsy and in selecting patients for surgical decompression. METHODS: Six patients with an acute inflammatory incomplete or complete peripheral facial nerve palsy (five idiopathic and one herpetic in origin) had repeated MR imaging studies with and without contrast enhancement, electroneurography, and clinical examinations to establish a connection between the intensity of contrast enhancement on MR images, the clinical condition, and the electrophysiological data. The examinations were performed every second day starting on the first day of admission until clinical recovery was proved by clinical deblockage (spontaneous clinical improvement). The last examination was performed 3 months after the onset of the facial nerve palsy. RESULTS: An abnormal, very intense contrast enhancement of the facial nerve was always present in the distal intrameatal and proximal tympanic segments and in the geniculate ganglion. The labyrinthine segment exhibited a mild to moderate enhancement, and the distal tympanic and mastoid segments showed a moderate to intense enhancement. The intensity of contrast enhancement did not correspond to the severity, duration, or course of the facial nerve palsy, and the electroneurographic data had no predictive value in indicating the severity of the inflammatory process. Three months after clinical recovery, a persistent and more or less unchanged or even slightly more intense contrast enhancement was observed. CONCLUSION: The long-lasting intense contrast enhancement seen in the facial nerve segments of patients who have acute peripheral inflammatory facial nerve palsy is explained by a two-phase breakdown of the blood-nerve barrier.
PURPOSE: To determine the value of MR contrast enhancement in predicting the course of acute inflammatory facial nerve palsy and in selecting patients for surgical decompression. METHODS: Six patients with an acute inflammatory incomplete or complete peripheral facial nerve palsy (five idiopathic and one herpetic in origin) had repeated MR imaging studies with and without contrast enhancement, electroneurography, and clinical examinations to establish a connection between the intensity of contrast enhancement on MR images, the clinical condition, and the electrophysiological data. The examinations were performed every second day starting on the first day of admission until clinical recovery was proved by clinical deblockage (spontaneous clinical improvement). The last examination was performed 3 months after the onset of the facial nerve palsy. RESULTS: An abnormal, very intense contrast enhancement of the facial nerve was always present in the distal intrameatal and proximal tympanic segments and in the geniculate ganglion. The labyrinthine segment exhibited a mild to moderate enhancement, and the distal tympanic and mastoid segments showed a moderate to intense enhancement. The intensity of contrast enhancement did not correspond to the severity, duration, or course of the facial nerve palsy, and the electroneurographic data had no predictive value in indicating the severity of the inflammatory process. Three months after clinical recovery, a persistent and more or less unchanged or even slightly more intense contrast enhancement was observed. CONCLUSION: The long-lasting intense contrast enhancement seen in the facial nerve segments of patients who have acute peripheral inflammatory facial nerve palsy is explained by a two-phase breakdown of the blood-nerve barrier.
Authors: H K Lim; J H Lee; D Hyun; J W Park; J L Kim; H y Lee; S Park; J H Ahn; J H Baek; C G Choi Journal: AJNR Am J Neuroradiol Date: 2011-12-29 Impact factor: 3.825
Authors: Maria Riga; G Kefalidis; A Chatzimoschou; G Tripsianis; S Kartali; H Gouveris; M Katotomichelakis; V Danielides Journal: Eur Arch Otorhinolaryngol Date: 2011-02-09 Impact factor: 2.503
Authors: Hartmut Peter Burmeister; Pascal Andreas Thomas Baltzer; Gerd Fabian Volk; Carsten Michael Klingner; Anke Kraft; Matthias Dietzel; Otto Wilhelm Witte; Werner Alois Kaiser; Orlando Guntinas-Lichius Journal: Eur Arch Otorhinolaryngol Date: 2011-02-05 Impact factor: 3.236
Authors: Bin Shen; Deepak Behera; Michelle L James; Samantha T Reyes; Lauren Andrews; Peter W Cipriano; Michael Klukinov; Amanda Brosius Lutz; Timur Mavlyutov; Jarrett Rosenberg; Arnold E Ruoho; Christopher R McCurdy; Sanjiv S Gambhir; David C Yeomans; Sandip Biswal; Frederick T Chin Journal: Theranostics Date: 2017-07-08 Impact factor: 11.556